Oral Lichen Planus: Clincal Features and Management
Oral lichen planus (OLP) is a chronic inflammatory disease commonly encountered in clinical dental practice. Although the etiology is unknown, an immu- nologically induced degeneration of the oral epithelial cells has been suggested. OLP can present in a number of forms: reticular, papular, plaque-like, atrophic, bullous and erosive. Topical steroids are the mainstay treatment for OLP. In this article we review the clinical features, process of diagnosis and management of OLP.
1. Bouquot JE, Gorlin RJ. Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years. Oral Surg Oral Med Oral Pathol 1986; 61: 373-81.
2. McCreary CE, McCartan BE. Clinical manage- ment of oral lichen planus. Br J Oral Maxillofac Surg 1999; 37: 338-43.
3. Scully C, Eisen D, Carrozzo M. Management of oral lichen planus. Am J Clin Dermatol 2000, 1: 287-306.
4. Scully C, el-Kom M. Lichen planus: review and update on pathogenesis. J Oral Pathol 1985; 14: 431-58.
5. Sugerman PB, Savage NW. Oral lichen planus: causes, diagnosis and management. Aust Dent J 2002:47:290-7.
6. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus, Crit Rev Oral Biol Med 2002: 13: 350-65.
7. Kilpi AM. Activation marker analysis of mono- nuclear cell infiltrates of oral lichen planus in situ. Scand J Dent Res 1987; 95:174-80.
8. Lundstrom IM. Incidence of diabetes mellitus in patients with oral lichen planus. Int J Oral Surg 1983: 12: 147-52.
9. Borghelli RF, Pettinari IL, Chuchurru JA, Stirparo MA. Oral lichen planus in patients with diabetes. An epidemiologic study. Oral Surg Oral Med Oral Pathol 1993; 75: 498-500.
10. Christensen E, Holmstrup P, Wiberg-Jorgensen F. at al. Arterial blood pressure in patients with oral lichen planus. J Oral Pathol 1977; 6: 139-42.
11. Scully C, Beyli M. Ferreiro MC, et al. Update on oral lichen planus: etiopathogenesis and manage-ment. Crit Rev Oral Biol Med 1998; 9:86-122.
12. Sugerman PB, Savage NW, Zhou X, et al. Oral lichen planus. Clin Dermatol 2000, 18:533-9.
13. Nagao Y. Sata M, Tanikawa K, et al. Lichen planus and hepatitis C virus in the northern Kyushu region of Japan. Eur J Clin Invest 1995; 25:910-4.
14. Jauregui L, Garcia-Patos V, Pedragosa R, et al. Lichen planus associated with liver disease caused by hepatitis C virus. Gastroenterol Hepatol 1996; 19:507-10.
15. Lodi G, Porter SR. Hepatitis C virus infection and lichen planus: a short review. Oral Dis 1997; 3: 77-81..
16. Klanrit P. Thongprasom K, Rojanawatsirivej S. et al. Hepatitis C virus infection in Thai patients with oral lichen planus. Oral Dis 2003; 9:292-7.
17. Hatchuel DA, Peters E, Lemmer J, et al. Candidal infection in oral lichen planus. Oral Surg Oral Med Oral Pathol 1990; 70: 172-5.
18. McCartan BE. Psychological factors associated with oral lichen planus. J Oral Pathol Med 1995; 24: 273-5.
19. Vallejo MJ, Huerta G, Cerero R, Seoane JM. Anxi- ety and depression as risk factors for oral lichen planus. Dermatology 2001; 203: 303-7.
20. Allen CM, Beck FM, Rossie KM, Kaul TJ, Rela- tion of stress and anxiety to oral lichen planus. Oral Sury Oral Med Oral Pathol 1986; 61: 44-6.
21. Strassburg M, Knolle G. Diseases of the oral mucosa. Quintessence Int 1974, 5: 53-60.
22. Mollaoglu N. Oral lichen planus: a review. Br J Oral Maxillofac Surg 2000, 38: 370-7.
23. กอบกาญจน์ ทองประสม, รอยโรคในช่องปากที่เกี่ยว ข้องกับความผิดปกติของระบบภูมิคุ้มกัน, พิมพ์ครั้งที่ 2. กรุงเทพฯ: สำนักพิมพ์แห่งจุฬาลงกรณ์มหาวิทยาลัย 2543: 25-56.
24. Eisen D. The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 1999; 88: 431-6.
25. Katta R. Lichen planus. Am Fam Physician 2000, 61:3319-28.
26. Jungell P. Oral lichen planus. A review. Int J Oral Maxillofac Surg 1991; 20: 129-35.
27. Edwards PC, Kelsch R. Oral lichen planus: clini cal presentation and management. J Can Dent Assoc 2002; 68: 494-9.
28. Andreasen JO. Oral lichen planus. 1. A clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol 1968; 25:31-42.
29. Bricker SL. Oral lichen planus: a review. Semin Dermatol 1994:13: 87-90.
30. Eisen D. The therapy of oral lichen planus. Crit Rev Oral Biol Med 1993; 4: 141-58.
31. Shklar G. Lichen planus as an oral ulcerative disease. Oral Surg Oral Med Oral Pathol 1972; 33:376-88.
32. Silverman S Jr. Oral lichen planus: a potentially premalignant lesion. J Oral Maxillofac Surg 2000, 58: 1286-8.
33. Holmstrup P. The controversy of a premalignant potential of oral lichen planus is over. Oral Surg Oral Med Oral Pathol 1992; 73:704-6.
34. Eisenberg E. Oral lichen planus: a benign lesion. J Oral Maxillofac Surg 2000; 58: 1278-85.
35. Voute AB, de Jong WF. Schulten EA, et al. Pos sible premalignant character of oral lichen planus. The Amsterdam experience. J Oral Pathol Med 1992; 21:326-9.
36. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978, 46: 518-39.
37. Mattsson U, Jontell M, Holmstrup P. Oral lichen planus and malignant transformation: is a recall of patients justified? Crit Rev Oral Biol Med 2002; 13:390-6.
38. Krutchkoff DJ, Eisenberg E. Lichenoid dysplasia: a distinct histopathologic entity. Oral Surg Oral Med Oral Pathol 1985; 60; 308-15.
39. McCartan B, McCreary C. What is the rationale for treating oral lichen planus? Oral Dis 1999, 5: 181-2.
40. Silverman S Jr. Lichen planus. Curr Opin Dent 1991: 1: 769-72.
41. Ellepola AN, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 2000; 11: 172-98.
42. Carbone M, Goss E, Carrozzo M, et al. Systemic and topical corticosteroid treatment of oral lichen. planus: a comparative study with long-term fol- low-up. J Oral Pathol Med 2003; 32: 323-9.
43. Lo Muzio L, della Valle A, Mignogna MD, et al. The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol pro- pionate in three preparations: a clinical and pilot study on 54 patients. J Oral Pathol Med 2001; 30: 611-7.
44. Voute AB, Schulten EA, Langendijk PN, et al. Fluocinonide in an adhesive base for treatment of oral lichen planus. A double-blind, placebo-con- trolled clinical study. Oral Surg Oral Med Oral Pathol 1993; 75: 181-5.
45. Thongprasom K. Luangjarmekorn L, Sererat T, Taweesap W. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 1992: 21:456-8.
46. Hegarty AM, Hodgson TA, Lewsey JD, Porter SR. Fluticasone propionate spray and betamethasone sodium phosphate mouthrinse: a randomized crossover study for the treatment of symptomatic oral lichen planus. J Am Acad Dermatol 2002; 47: 271-9.
47. Lozada-Nur F, Miranda C, Maliksi R. Double-blind clinical trial of 0.05% clobetasol propionate (cor- rected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive dis- cases. Oral Surg Oral Med Oral Pathol 1994, 77: 398-604.
48. Carbone M, Conrotto D, Carrozzo M. Topical cor- ticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-crosive oral lichen planus: a placebo-con- trolled and comparative study between clobetasol and fluocinonide. Oral Dix 1999; 5:44-9.
49. Carrozzo M, Gandolfo S. The management of oral lichen planus. Oral Dis 1999: 5: 196-205.
50. Lozada NF, Silverman S Jr, Migliorati C. Adverse side effects associated with prednisone in the treat- ment of patients with oral inflammatory ulcerative diseases, JADA 1984: 109: 269-70.
51. Vincent SD, Fotos PG, Baker KA, Williams TP. Oral lichen planus: the clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 1990; 70: 165-71.
52. Silverman S Jr, Lozada-Nur F. Migliorati C. Clini cal efficacy of prednisone in the treatment of patients with oral inflammatory ulcerative diseases: a study of fifty-five patients. Oral Surg Oral Med Oral Pathol 1985: 59: 360-3.
53. Zegarelli DJ. Multimodality steroid therapy of erosive and ulcerative oral lichen planus. J Oral Med 1983; 38: 127-30.
54. Vincent SD. Diagnosing and managing oral lichen planus. J Am Dent Assoc 1991; 122: 93-4, 96.
55. Gunther SH. The therapeutic value of retinoic acid (vitamin A acid) in lichen planus of the oral mucous membrane. Dermatologica 1973; 147: 130-6.
56. Giustina TA, Stewart JC, Ellis CN, et al. Topical application of isotretinoin gel improves oral lichen planus. A double-blind study. Arch Dermatol 1986: 122:534-6.
57. Stuttgen G. Therapy with vitamin A acid. Skin Pharmacol 1993: 6 Suppl 1: 3-7.
58. Schuppli R. The efficacy of a new retinoid (Ro 10- 9359) in lichen planus. Dermatologica 1978; 157: 60-3.
59. Gorsky M. Raviv M. Efficacy of etretinate (Tigason) in symptomatic oral lichen planus. Oral Surg Oral Med Oral Pathol 1992; 73: 52-5.
60. Ferguson MM. Simpson NB, Hammersley N. The treatment of erosive lichen planus with a retin- oid etretinate. Oral Surg Oral Med Oral Pathol 1984; 58: 283-7.
61. Ho VC, Conklin RJ. Effect of topical cyclosporine rinse on oral lichen planus. N Engl J Med 1991; 325:435.
62. Ho VC, Gupta AK, Ellis CN, et al. Treatment of severe lichen planus with cyclosporine. J Am Acad Dermatol 1990; 22:64-8.
63. Horch HH, Gerlach KL, Schaefer HE. CO2 laser surgery of oral premalignant lesions. Int J Oral Maxillofac Surg 1986; 15: 19-24.
64. Tal H. Rifkin B. Cryosurgical treatment of a gin gival lichen planus: report of case. J Am Dent Assoc 1986; 113:629-31.